$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Delayed onset transdermal delivery device 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61F-013/02
출원번호 US-0271207 (1988-11-14)
발명자 / 주소
  • Lee Eun Soo (Redwood City CA) Theeuwes Felix (Los Altos Hills CA) Wong Patrick S. L. (Hayward CA) Yum Su Il (Los Altos CA) Zaffaroni Alejandro (Atherton CA)
출원인 / 주소
  • ALZA Corporation (Palo Alto CA 02)
인용정보 피인용 횟수 : 54  인용 특허 : 0

초록

A diffusional drug delivery device is described which can provide for delayed onset of therapeutic effect and for delivery of the therapeutic agent in predetermined temporal patterns at optimum rates. Delay means are provided between the agent reservoir and the surface through which the agent is rel

대표청구항

A controlled release medical device for delivering nitroglycerin to skin or mucosa and adapted to delay the onset of nitroglycerin delivery at a therapeutically effective rate for a predetermined time after placement of said device in nitroglycerin transferring relationship to the skin or mucosa, sa

이 특허를 인용한 특허 (54)

  1. Govil, Sharad K.; Weimann, Ludwig J., Adhesive mixture for transdermal delivery of highly plasticizing drugs.
  2. Govil, Sharad K.; Weimann, Ludwig J., Adhesive mixture for transdermal delivery of highly plasticizing drugs.
  3. Govil,Sharad K.; Weimann,Ludwig J., Adhesive mixture for transdermal delivery of highly plasticizing drugs.
  4. Govil,Sharad K.; Weimann,Ludwig J., Adhesive mixture for transdermal delivery of highly plasticizing drugs.
  5. To, John Thao; Blaha, Charles M., Coating system and method for drug elution management.
  6. Bozik, Michael E.; Petzinger, Jr., Thomas; Mather, James L.; Archibald, Donald, Compositions and methods for treating amyotrophic lateral sclerosis in responders.
  7. Bozik, Michael E.; Petzinger, Jr., Thomas; Mather, James L.; Archibald, Donald, Compositions and methods for treating amyotrophic lateral sclerosis in responders.
  8. Bozik, Michael E.; Dworetzky, Steven, Compositions and methods for treating chronic urticaria.
  9. Bozik, Michael E; Dworetzky, Steven, Compositions and methods for treating chronic urticaria.
  10. Bozik, Michael E.; Hebrank, Gregory; Farwell, Wildon; Petzinger, Jr., Thomas; Dworetzky, Steven, Compositions and methods for treating conditions related to increased eosinophils.
  11. Bozik, Michael E.; Dworetzky, Steven, Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders.
  12. Bozik, Michael E.; Dworetzky, Steven, Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders.
  13. Bozik, Michael E.; Gribkoff, Valentin; Petzinger, Jr., Thomas, Compositions and methods of using (R)-pramipexole.
  14. Bozik, Michael E.; Petzinger, Jr., Thomas; Gribkoff, Valentin, Compositions and methods of using (R)-pramipexole.
  15. Bozik, Michael E.; Petzinger, Jr., Thomas; Gribkoff, Valentin, Compositions of R(+) and S(−) pramipexole and methods of using the same.
  16. Bozik, Michael E.; Petzinger, Jr., Thomas; Gribkoff, Valentin, Compositions of R(+) and S(−) pramipexole and methods of using the same.
  17. Mak,Vivien H. W.; Grayson,Stephen, Compounds and methods for the treatment of urogenital disorders.
  18. Brekke, John H.; Bradica, Gino; Goldman, Scott M., Device for regeneration of articular cartilage and other tissue.
  19. Brekke, John H.; Bradica, Gino; Goldman, Scott M., Device for regeneration of articular cartilage and other tissue.
  20. Massengale, Roger; Dine, Alan; Forrest, Kevin M.; Porter, Bill; Earhart, Donald M., Fluid medication delivery device.
  21. Massengale, Roger; Forrest, Kevin M.; Porter, Bill; Earhart, Donald M.; Dine, Alan, Fluid medication delivery device.
  22. Massengale, Roger; Forrest, Kevin M.; Porter, Bill; Earhart, Donald M.; Dine, Alan, Fluid medication delivery device.
  23. Massengale, Roger; Forrest, Kevin M.; Porter, Bill; Earhart, Donald M.; Dine, Alan, Fluid medication delivery device.
  24. Massengale,Roger; Forrest,Kevin M.; Porter,Bill; Earhart,Donald M.; Dine,Alan, Fluid medication delivery device.
  25. van Osdol, William W.; Crisologo, Nieves M.; Yum, Su Il, Formulations for the transdermal administration of fenoldopam.
  26. van Osdol, William W.; Crisologo, Nieves M.; Yum, Su Il, Formulations for the transdermal administration of fenoldopam.
  27. Theeuwes, Felix; Nelson, Timothy S., Implantable drug delivery patch.
  28. Hyatt Gary F. ; Bostic William M., Medical applicator and method.
  29. Shlenker Robin Renee Thill ; Lester David J. ; Solomons Clive C. ; Plamthottam Sebastian S., Method of forming a membrane especially a latex or polymer membrane including multiple discrete layers.
  30. Shlenker Robin Renee Thill (Malibu CA) Lester David J. (Littleton CO) Solomons Clive C. (Denver CO) Plamthottam Sebastian S. (Upland CA), Method of forming a membrane, especially a latex or polymer membrane, including multiple discrete layers.
  31. Adams, Michael A.; Heaton, Jeremy P. W.; Banting, James D., Microdose therapy.
  32. Heaton,Jeremy P. W.; Adams,Michael A.; Banting,James D., Microdose therapy.
  33. Jeremy P. W. Heaton CA; Michael A. Adams CA; James D. Banting CA, Microdose therapy.
  34. Bozik, Michael E.; Petzinger, Jr., Thomas; Gribkoff, Valentin, Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same.
  35. Lee Eun Soo ; Watanabe Tyler ; Gale Robert M. ; Burkoth Terry L., Monoglyceride/lactate ester permeation enhancer for oxybutnin.
  36. Geoghegan, Edward James; Mulligan, Seamus; Foynes, Mary Margaret, Pharmaceutical formulations for preventing drug tolerance.
  37. Hoganson, David M.; Bradica, Gino; Goldman, Scott M.; Brekke, John H., Resorbable polymeric device for localized drug delivery.
  38. Miranda Jesus ; Sablotsky Steven, Solubility parameter based drug delivery system and method for altering drug saturation concentration.
  39. Miranda Jesus ; Sablotsky Steven, Solubility parameter based drug delivery system and method for altering drug saturation concentration.
  40. Chen, Weirong; Humora, Michael; Kwok, Daw-Iong Albert; Kiesman, William F.; Irdam, Erwin Ayandra, Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds.
  41. Chen, Weirong; Humora, Michael; Kwok, Daw-long Albert; Kiesman, William F.; Irdam, Erwin Ayandra, Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds.
  42. Raje, Prasad; Gadikota, Rajendrakumar Reddy; Chen, Jian-Xie; Lapina, Olga V.; McCall, John M., Synthesis of chirally purified substituted benzothiazole diamines.
  43. Raje, Prasad; Gadikota, Rajendrakumar Reddy; Chen, Jian-Xie; Lapina, Olga V.; McCall, John M., Synthesis of chirally purified substituted benzothiazole diamines.
  44. Chien Yie W. ; Chen Guo-Shen,CNX ; Chien Te-Yen, Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes.
  45. Svedman Pal,SEX, Transdermal device for administration through de-epithelialized skin.
  46. Watanabe, Tyler; Gale, Robert M., Transdermal drug delivery device package with improved drug stability.
  47. Bevan Bruno,FRX ; Aillaud Cecile,FRX, Transdermal system for simultaneous delivery of a number of active principles.
  48. Deshmukh, Abhijit Mukund; Dixit, Akhilesh; Kumar, Prasanna; Bindra, Vikram, Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders.
  49. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  50. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  51. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  52. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  53. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  54. Bond, Richard A.; Glass, Mitchell, Use of beta-adrenergic inverse agonists for smoking cessation.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로